Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Iovance Biotherapeutics
Sort By
Newest First
Sign in
1 / 1
1 / 1
Phase II
Iovance Biotherapeutics Provides Cervical Cancer Program Updates Following End of Phase 2 Meeting with U.S. Food and Drug Administration (FDA)
Iovance Biotherapeutics, Inc.
PR-M07-19-NI-016
Jul 08, 2019
Market Expansion
Iovance Announces Plans to Build Cell Therapy Production Plant in U.S.
Emilie Branch
Pharma's Almanac
PAO-M06-19-NI-005
Jun 13, 2019
New Facility
Iovance Biotherapeutics Announces New Facility to Support U.S. Production of Tumor Infiltrating Lymphocyte Cell Therapy Products
Nice Insight
PR-M05-19-NI-082
May 30, 2019
